<![CDATA[Enzon Pharmaceuticals Inc. | Company News & Executive Profiles - ENZN | BNET]]> en-us <![CDATA[Enzon to Release Third Quarter 2008 Earnings on Wednesday, November 5, 2008; Conference Call and Webcast to Follow]]> Wed, 29 Oct 2008 23:59:59 -0700 ENZN NDAQ ENZN,NDAQ <![CDATA[Enzon Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript]]> Mon, 11 Aug 2008 15:47:12 -0700 ENZN ENZN <![CDATA[Enzon Files for Spin-off of Biotech Business]]> Thu, 31 Jul 2008 23:59:59 -0700 ENZN ENZN <![CDATA[Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow]]> Tue, 29 Jul 2008 23:59:59 -0700 ENZN NDAQ ENZN,NDAQ <![CDATA[Enzon Announces Clinical Data from PEG-SN38 and rhMBL Studies at ASCO]]> Tue, 20 May 2008 23:59:59 -0700 ENZN ENZN <![CDATA[Enzon Pharmaceuticals Inc., Q1 2008 Earnings Call Transcript]]> Wed, 07 May 2008 11:59:09 -0700 ENZN ENZN <![CDATA[Enzon Pharmaceuticals, Inc. Announces FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis.]]> Fri, 20 Apr 2007 23:59:59 -0700 ENZN NDAQ ENZN,NDAQ <![CDATA[Enzon Pharmaceuticals Prices Convertible Senior Notes]]> Thu, 18 May 2006 23:59:59 -0700 ENZN NDAQ ENZN,NDAQ <![CDATA[Enzon to File Extension for Fiscal 2005 Form 10-K Filing]]> Mon, 12 Sep 2005 23:59:59 -0700 ENZN ENZN <![CDATA[Enzon to Present at Bear Stearns Healthcare Conference]]> Fri, 09 Sep 2005 23:59:59 -0700 ENZN ENZN